| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.625 | 14.690 | 21.184 | 22.955 | 20.107 | 16.539 | 16.460 | 23.668 | 20.826 | 26.372 |
| Total Income - EUR | 13.274 | 18.082 | 21.336 | 23.701 | 20.546 | 17.921 | 18.022 | 24.211 | 21.007 | 26.598 |
| Total Expenses - EUR | 9.836 | 13.163 | 9.720 | 18.379 | 16.387 | 11.472 | 12.968 | 12.129 | 14.533 | 19.575 |
| Gross Profit/Loss - EUR | 3.438 | 4.919 | 11.616 | 5.322 | 4.159 | 6.449 | 5.054 | 12.082 | 6.473 | 7.024 |
| Net Profit/Loss - EUR | 2.963 | 4.376 | 11.072 | 5.085 | 3.954 | 6.288 | 4.883 | 11.840 | 6.263 | 6.758 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Venom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.105 | 10.618 | 8.976 | 11.852 | 8.896 | 6.054 | 3.305 | 2.551 | 2.404 | 3.001 |
| Current Assets | 11.150 | 4.784 | 8.238 | 7.311 | 3.687 | 9.304 | 4.008 | 18.882 | 19.225 | 7.710 |
| Inventories | 48 | 37 | 61 | 75 | 61 | 220 | 128 | 117 | 862 | 199 |
| Receivables | 3.932 | 2.462 | 2.359 | 1.627 | 1.196 | 1.108 | 801 | 1.502 | 883 | 3.934 |
| Cash | 7.170 | 2.285 | 5.819 | 5.609 | 2.430 | 7.976 | 3.079 | 17.264 | 17.480 | 3.577 |
| Shareholders Funds | 22.571 | 11.247 | 11.116 | 15.997 | 7.739 | 13.881 | 5.689 | 12.926 | 19.150 | 9.497 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.684 | 4.154 | 6.098 | 3.166 | 4.844 | 1.478 | 1.624 | 8.508 | 2.479 | 1.214 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4931 - 4931" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - Venom Srl